Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1009-2020

Drug recall · March 18, 2020

Ertapenem in 100ML 0.9% NACL 1GM Injectable recall

Why: Lack Of Processing Controls

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Lots / codes

Lot 02242020@7

Quantity
8 doses
Company
Redline Pharmacy Solutions, Hastings, NE
Distribution
Sold to patients in Nebraska
Initiated
February 24, 2020 · Voluntary: Firm initiated
Classified
March 12, 2020
Reported
March 18, 2020
Ended
March 31, 2022
How notified
Telephone

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Ertapenem

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.